1. Clinical characteristics and histopathology of COVID-19 related deaths in South African adults
- Author
-
Nana Thwala, Shabir A. Madhi, Colin N. Menezes, Natali Serafin, Marta C. Nunes, Marius Laubscher, Vicky L Baillie, Sana Mahtab, Toyah Els, Martin Hale, Shakeel Mc Kenzie, Brian Dulisse, Fikile C Mabena, Sarah van Blydenstein, Noluthando Dludlu, Sihle Mtshali, Merika Tsitsi, and Jeanine Du Plessis
- Subjects
Male ,RNA viruses ,Viral Diseases ,Pulmonology ,Coronaviruses ,Physiology ,Respiratory System ,Comorbidity ,Pneumocytes ,South Africa ,Medical Conditions ,Informed consent ,Medicine and Health Sciences ,Respiratory system ,Immune Response ,Pathology and laboratory medicine ,Virus Testing ,Multidisciplinary ,biology ,Respiratory distress ,Respiratory disease ,Middle Aged ,Medical microbiology ,Actinobacteria ,medicine.anatomical_structure ,Infectious Diseases ,COVID-19 Nucleic Acid Testing ,Hypertension ,Viruses ,Medicine ,Vaccine-preventable diseases ,Female ,Autopsy ,SARS CoV 2 ,Pathogens ,Anatomy ,Research Article ,Adult ,medicine.medical_specialty ,SARS coronavirus ,Science ,Immunology ,Alveoli ,Real-Time Polymerase Chain Reaction ,Microbiology ,Mycobacterium tuberculosis ,Respiratory Disorders ,Signs and Symptoms ,Diagnostic Medicine ,Internal medicine ,medicine ,Diabetes Mellitus ,Humans ,Respiratory Physiology ,Pandemics ,Aged ,Inflammation ,Lung ,Biology and life sciences ,Bacteria ,business.industry ,SARS-CoV-2 ,Organisms ,Viral pathogens ,COVID-19 ,Covid 19 ,Length of Stay ,biology.organism_classification ,medicine.disease ,Microbial pathogens ,Alveolar Epithelial Cells ,Respiratory Infections ,Histopathology ,Biopsy, Large-Core Needle ,Clinical Medicine ,business ,Mycobacterium Tuberculosis - Abstract
Comparisons of histopathological features and microbiological findings between decedents with respiratory symptoms due to SARS-CoV-2 infection or other causes, in settings with high prevalence of HIV and Mycobacterium tuberculosis (MTB) infections have not been reported. Deaths associated with a positive ante-mortem SARS-CoV-2 PCR test and/or respiratory disease symptoms at Chris Hani Baragwanath Academic Hospital in Soweto, South Africa from 15th April to 2nd November 2020, during the first wave of the South African COVID-19 epidemic, were investigated. Deceased adult patients had post-mortem minimally-invasive tissue sampling (MITS) performed to investigate for SARS-CoV-2 infection and molecular detection of putative pathogens on blood and lung samples, and histopathology examination of lung, liver and heart tissue. During the study period MITS were done in patients displaying symptoms of respiratory disease including 75 COVID-19-related deaths (COVID+) and 42 non-COVID-19-related deaths (COVID-). The prevalence of HIV-infection was lower in COVID+ (27%) than in the COVID- (64%), MTB detection was also less common among COVID+ (3% vs 13%). Lung histopathology findings showed differences between COVID+ and COVID- in the severity of the morphological appearance of Type-II pneumocytes, alveolar injury and repair initiated by SARS-CoV-2 infection. In the liver necrotising granulomatous inflammation was more common among COVID+. No differences were found in heart analyses. The prevalence of bacterial co-infections was higher in COVID+. Most indicators of respiratory distress syndrome were undifferentiated between COVID+ and COVID- except for Type-II pneumocytes. HIV or MTB infection does not appear in these data to have a meaningful correspondence with COVID-related deaths. Funding Information: This study was supported by the Bill & Melinda Gates Foundation (grant number INV-016202). There was also partial support from the Department of Science and Technology and National Research Foundation: South African Research Chair Initiative in Vaccine Preventable Diseases; and the South African Medical Research Council. Declaration of Interests: All other authors have nothing to disclose. Ethics Approval Statement: The study was approved by the Human Research Ethics Committee at the University of the Witwatersrand (HREC approval number: M200313). Informed consent was obtained from relatives of the deceased.
- Published
- 2022